Dramatic improvement of inoperable angiosarcoma with combination paclitaxel and bevacizumab chemotherapy. J Am Acad Dermatol 2010 Oct;63(4):e83-4
Date
09/18/2010Pubmed ID
20846560DOI
10.1016/j.jaad.2009.09.035Scopus ID
2-s2.0-77956717395 (requires institutional sign-in at Scopus site) 35 CitationsAuthor List
Fuller CK, Charlson JA, Dankle SK, Russell TJAuthor
John A. Charlson MD Associate Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AgedAntibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Biopsy, Needle
Dose-Response Relationship, Drug
Drug Administration Schedule
Facial Neoplasms
Follow-Up Studies
Hemangiosarcoma
Humans
Immunohistochemistry
Male
Neoplasm Invasiveness
Neoplasm Staging
Paclitaxel
Treatment Outcome
